
Sign up to save your podcasts
Or


Today, Ivelisse talks with Dr. Dan Rubin, a naturopathic oncologist and co-founder of Naturopathic Specialists in Scottsdale, Arizona, about an emerging cancer treatment called dendritic cell therapy.
Dr. Rubin explains in simple terms how dendritic cells act like “generals” of the immune system—gathering information about a tumor and teaching the body’s T cells how to recognize and attack cancer. He discusses Immunocine’s “double-loaded” dendritic cell therapy, which uses information from a patient’s own tumor to help train the immune system in a more personalized way. This treatment is currently offered in Cancun and is also being studied in U.S. clinical trials for certain cancers, including glioblastoma and pancreatic cancer.
They walk through what the process looks like for patients—from application and medical record review, to traveling for tumor sampling, collecting immune cells, and receiving a series of injections. Dr. Rubin also shares how tumor tissue can be stored for possible future use and talks honestly about outcomes, cost, and the importance of ongoing testing to determine who may benefit most.
This episode provides hope-filled, easy-to-understand insight into a personalized, immune-based approach to cancer care for patients and caregivers alike.
Learn more about Dr. Dan Rubin.
Suggested Resources:
Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now! 🌟
By Ivelisse Page4.7
5252 ratings
Today, Ivelisse talks with Dr. Dan Rubin, a naturopathic oncologist and co-founder of Naturopathic Specialists in Scottsdale, Arizona, about an emerging cancer treatment called dendritic cell therapy.
Dr. Rubin explains in simple terms how dendritic cells act like “generals” of the immune system—gathering information about a tumor and teaching the body’s T cells how to recognize and attack cancer. He discusses Immunocine’s “double-loaded” dendritic cell therapy, which uses information from a patient’s own tumor to help train the immune system in a more personalized way. This treatment is currently offered in Cancun and is also being studied in U.S. clinical trials for certain cancers, including glioblastoma and pancreatic cancer.
They walk through what the process looks like for patients—from application and medical record review, to traveling for tumor sampling, collecting immune cells, and receiving a series of injections. Dr. Rubin also shares how tumor tissue can be stored for possible future use and talks honestly about outcomes, cost, and the importance of ongoing testing to determine who may benefit most.
This episode provides hope-filled, easy-to-understand insight into a personalized, immune-based approach to cancer care for patients and caregivers alike.
Learn more about Dr. Dan Rubin.
Suggested Resources:
Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now! 🌟

3,939 Listeners

7,310 Listeners

2,323 Listeners

924 Listeners

9,254 Listeners

8,007 Listeners

169 Listeners

2,027 Listeners

1,334 Listeners

14,707 Listeners

909 Listeners

2,248 Listeners

1,264 Listeners

1,397 Listeners

220 Listeners